Associated Papers
Influence of polymorphisms in CYP2C9, VKORC1, MDR1 and APOE genes on the warfarin maintenance dose in Brazilian patients.
de Freitas Campos EI et al.
Pharmacogenomics, 2023
Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin.
Xia X et al.
European Journal of Clinical Pharmacology, 2022
Algorithm for predicting low maintenance doses of warfarin using age and polymorphisms in genes CYP2C9 and VKORC1 in Brazilian subjects.
de Oliveira Magalhães Mourão A et al.
The Pharmacogenomics Journal, 2020
Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin.
Praxedes MFS et al.
European Journal of Clinical Pharmacology, 2020
Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews.
Zhou Y et al.
Journal of Medical Genetics, 2018
Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study.
de Oliveira Almeida VC et al.
Molecular Diagnosis & Therapy, 2014
Pharmacogenetics of warfarin: current status and future challenges.
Wadelius M et al.
The Pharmacogenomics Journal, 2007
Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.
Yin T et al.
Thrombosis Research, 2007
Select a paper to view details